A devastating missile and drone attack by Russia on Kyiv has left at least 14 injured. President Zelensky condemns the assault, calling for further sanctions against Moscow amidst ongoing conflict.
In a surprising move, the Trump administration has dramatically downsized the National Security Council, dismissing numerous staffers under new adviser Marco Rubio. This shift raises questions about the future of U.S. foreign policy and national security coordination.
Microsoft's new AI model, Aurora, promises to revolutionize weather forecasting by predicting hurricanes and other atmospheric events with unprecedented accuracy and speed. Discover how this technology outperforms traditional methods!
Don't miss out on the incredible Memorial Day deals for LG G4 Series OLED TVs! Grab a stunning 77-inch model for just $2,997 and elevate your home entertainment experience with unbeatable picture quality!
Get ready for the Ancients Recovered event in Pokémon GO! Join forces in global raids featuring all Regi Pokémon and earn exclusive rewards. Don't miss the chance to capture shiny variants and complete exciting research tasks!
Google has announced that AI Mode reporting will soon be integrated into Google Search Console. John Mueller confirmed that while it's not live yet, updates are coming to help users navigate AI Mode traffic and its implications for search performance.
The Samsung Galaxy S25 Edge impresses with its design but disappoints with its battery life. Testing reveals it struggles to keep up with its siblings, raising questions about its long-term usability.
After the shocking death of her fit father from myeloma just weeks after misdiagnosis, a devastated stepdaughter calls for better awareness of cancer symptoms among GPs. Her journey includes running a marathon to raise funds for Myeloma UK.
The new COVID-19 variant NB.1.8.1 is making waves globally with rising cases linked to its emergence. Learn about its symptoms, transmissibility, and what health authorities are saying.
A groundbreaking study shows that GLP-1 diabetes drugs may reduce the risk of obesity-related cancers by 7% compared to DPP-4 inhibitors, particularly in women. Discover the implications for diabetes treatment!
